Mandating COVID Shots âOne of the Greatest Mistakes,â Former CDC Chief Says
In a Senate hearing Thursday, ex-CDC Director Robert Redfield said mRNA COVID-19 vaccines are âtoxicâ and should not have been mandated. He also called for a pause on gain-of-function research.

Former Centers for Disease Control and Prevention (CDC) Director Robert Redfield confirmed the dangers of mRNA COVID-19 vaccines in a U.S. Senate hearing Thursday, calling them âtoxicâ and saying they should never have been mandated.
Redfieldâs admissions came during a Senate Committee on Homeland Security and Governmental Affairs hearing on government oversight of taxpayer-funded high-risk virus research.
The late admission of vaccine injuries underscores the failure of public health agencies and the medical establishment to provide informed consent to the billions of vaccine recipients worldwide.
âItâs important that he is telling the truth now,â vaccine researcher Jessica Rose, Ph.D., told The Defender. âAdverse events were hidden and still are being hidden to prevent injection hesitancy.â
Redfield, who led the CDC from 2018 to 2021, didnât stop there. He declared biosecurity âour nationâs greatest national security threat,â calling for a halt to gain-of-function researchpending further debate.
The hearing, which featured contentious exchanges between senators and witnesses, also touched on controversial topics such as the COVID-19 origins lab-leak theory and allegations that health agencies suppressed data.
mRNA vax âshould have been open to personal choiceâ
During the hearing Redfield, who oversaw the CDC during the crucial early months of the COVID-19 pandemic, elaborated on his recent statements about mRNA vaccine safety.
âI do think one of the greatest mistakes that was made, of course, was mandating these vaccines,â Redfield said. âThey should have never been mandated. It should have been open to personal choice.â
Redfield went further, admitting that the spike protein produced by mRNA vaccines is âtoxic to the bodyâ and triggers âa very strong pro-inflammatory response.â
He noted that in his own medical practice, he doesnât administer mRNA vaccines, preferring âkilled protein vaccinesâ instead.
Redfieldâs statements stand in stark contrast to the CDCâs official stance during his tenure, which strongly promoted mRNA vaccine uptake as safe and effective.
Sen. Ron Johnson (R-Wis.) pressed Redfield on the issue, highlighting concerning data from the Vaccine Adverse Event Reporting System (VAERS). Johnson presented figures showing over 37,000 deaths reported following COVID-19 vaccination, with 24% occurring within two days of injection.
Redfield acknowledged there was ânot appropriate transparency from the beginning about the potential side effects of these vaccines.â He criticized attempts to âunderreport any side effects because they argued that would make the public less likely to get vaccinated.â
âFDA should release all of the safety dataâ
Redfieldâs criticism of data withholding extended beyond vaccine side effects. He expressed disappointment in the U.S. Food and Drug Administrationâs (FDA) handling of vaccine safety information.
âThe FDA should release all of the safety data they have,â Redfield said. âI was very disappointed to hear that they were planning to hold on to that until 2026. That really creates a sense of total lack of trust in our public health agencies towards vaccination.â
Johnson echoed these concerns, revealing his frustration with the lack of follow-through by health agencies and the committee itself.
âIâm not getting cooperation out of the chairman of the permanent subcommittee investigation to issue subpoenas to get this,â Johnson said, referring to unreleased data and documents.
The senator displayed a chart comparing adverse event reports for various drugs, including ivermectin and hydroxychloroquine, to those for COVID-19 vaccines. The stark contrast in reported deaths from these therapeutics â with COVID-19 vaccines showing significantly higher numbers â fueled Johnsonâs demand for more transparency.
âAs important as the cover-up of the origin story is, thereâs a lot more thatâs being covered up,â Johnson asserted. âThe public has a right to know. We pay for these agencies. We pay their salaries. We fund these studies.â
Redfield agreed with Johnsonâs assessment, stating that withholding the information is âcounterproductive.â
Redfield doubtful of âany benefit from [gain-of-function] researchâ
Redfieldâs testimony took another controversial turn when he called for a pause on gain-of-function research, experiments that involve making pathogens more infectious or deadly.
âIâm not aware of any advanced therapeutic or vaccine that has come to pass because of gain-of-function research,â Redfield said. âI do think there has to be a very aggressive debate of whether thereâs any benefit from that research.â
Sen. Rand Paul (R-Ky.) seized on this point, introducing his Risky Research Review Act. The bill aims to establish an independent board within the executive branch to oversee federal funding for high-risk life sciences research.
âIf the Risky Research Review Act had been in place, it might have prevented the COVID-19 pandemic,â Paul said, citing Redfieldâs endorsement.
MITâs Kevin Esvelt, Ph.D., inventor of a technique for rapidly evolving proteins and other biomolecules who was also instrumental in developing CRISPR gene-editing technology, reinforced these concerns.
Highlighting gaps in current oversight, he described an experiment where his team â with FBI approval â successfully ordered DNA fragments of the 1918 influenza virus from 36 of 38 providers.
âEverything that we did and the companies did was entirely legal,â Esvelt said, underscoring the potential for misuse. âThere are no laws regulating DNA synthesis, even though the industry group, the International Gene Synthesis Consortium, has requested congressional regulation.â
The hearing revealed a growing consensus among witnesses for stricter oversight of potentially dangerous research, with Redfield suggesting such studies should be âhighly regulatedâ to protect national security.
Redfield reaffirms COVID lab-leak theory
The hearing reignited debate over the origins of COVID-19, with Redfield reaffirming his belief in the lab-leak theory.
âBased on my initial analysis, I believe then, and I still believe today, that the COVID infections were the direct result of a biomedical research experiment and subsequent lab leak,â Redfield stated.
This assertion led to a heated exchange between Sen. Josh Hawley (R-Mo.) and Carrie Wolinetz, Ph.D., former chief of staff to then-director of the National Institutes of Health (NIH) Francis Collins. Hawley accused NIH officials of deliberately suppressing the lab-leak theory.
âYour office, Dr. [Anthony] Fauci and others tried to actively censor them,â Hawley said. âThere was a propaganda effort that this paper was the center of, and now everybody says, âOh, well, we just werenât sure at the time.ââ
Hawley referred to the 2020 âProximal Originâ paper that argued against the lab-leak hypothesis.
Wolinetz defended the NIHâs actions. âI do not believe censorship took place, sir.â She maintained that discussions about the virusâs origins were part of normal scientific discourse.
Redfield, however, criticized the lack of thorough investigation into both natural origin and lab-leak hypotheses. âUnfortunately, this didnât happen,â he said, adding that four years later, he believes thereâs no meaningful evidence supporting a natural origin.
The former CDC director also revealed that he did not learn about concerning biodistribution studies of the vaccineâs lipid nanoparticles until as late as the summer of 2021, suggesting a delay in critical information reaching top health officials.
This article was funded by critical thinkers like you.
The Defender is 100% reader-supported. No corporate sponsors. No paywalls. Our writers and editors rely on you to fund stories like this that mainstream media wonât write.
âBiosecurity is our nationâs greatest national security threatâ
Redfield emphasized the critical importance ofbiosecurity in national defense.
âIn 2024, 2025, biosecurity is our nationâs greatest national security threat,â Redfield stated. âYou need to think of it the same way we thought about the verge of nuclear atomic [sic] in the late 40s, 50s, and 60s.â
He called for a proportional response to the threat, suggesting the creation of a dedicated agency within the U.S. Department of Energy to address biosecurity concerns.
âWe have a $900 billion Defense Department for the threat of China, North Korea and Russia,â Redfield noted. âWe donât have really any systematic agency or network of private sector contractors to help us with the biosecurity threat.â
Sen. Roger Marshall (R-Kan.) echoed this sentiment. âIn my humble mind, a viral biosecurity issue is a bigger issue than Chinaâs military threat to us.â
Gerald Parker, DVM, Ph.D., associate dean forGlobal One Health at Texas A&M University, supported the call for enhanced oversight, recommending âan independent authority to consolidate secure functions in a single entity with a dedicated mission.â
The hearing also touched on the potential for future pandemics, with Redfield repeating his warnings about the potential spread of H5N1 bird flu.
As the hearing concluded, senators from both parties expressed concern over the lack of transparency and oversight in high-risk research.
Paul summarized the sentiment: âWe cannot stand idly by. We must demand accountability, strive for transparency and ensure the safety of our citizens is never again compromised by negligence or deceit.â
Watch the July 11 hearing: âRisky Researchâ:
No comments:
Post a Comment